Zdrowie i gospodarka · 02/04/2015

FDA Releases Guidance on Abuse-Deterrent Opioids for Pharmaceutical Industry

The Food and Drug Administration (FDA) has published a guidance document outlining its approach to evaluating and labeling opioid formulations with abuse-deterrent properties, aiming to assist pharmaceutical companies in developing such products.